Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOLUTEGRAVIR\LAMIVUDINE for Hiv test: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where DOLUTEGRAVIR\LAMIVUDINE was used for Hiv test.

Most Reported Side Effects for DOLUTEGRAVIR\LAMIVUDINE

Side Effect Reports % Deaths Hosp.
Product dose omission issue 1,089 34.3% 1 16
Inappropriate schedule of product administration 256 8.1% 0 2
Product dose omission in error 234 7.4% 0 2
Product use issue 194 6.1% 3 4
Drug ineffective 137 4.3% 3 4
Pathogen resistance 137 4.3% 0 2
Intentional dose omission 112 3.5% 0 0
Viral load increased 104 3.3% 0 4
Rash 99 3.1% 2 14
Treatment noncompliance 97 3.1% 1 7
Viral mutation identified 94 3.0% 0 0
Adverse drug reaction 93 2.9% 0 0
Incorrect dose administered 92 2.9% 0 0
Off label use 92 2.9% 3 3
Fatigue 78 2.5% 3 6

Other Indications for DOLUTEGRAVIR\LAMIVUDINE

Hiv infection (1,603) Product used for unknown indication (1,305) Hiv infection cdc group iii (51) Antiretroviral therapy (28) Acquired immunodeficiency syndrome (22) Hiv carrier (20) Hiv test positive (13) Antiviral treatment (5) Hepatitis c (5)

Other Drugs Used for Hiv test

CABOTEGRAVIR (64) CABOTEGRAVIR\RILPIVIRINE (35) RILPIVIRINE (35) DOLUTEGRAVIR (23) ABACAVIR\DOLUTEGRAVIR\LAMIVUDINE (17) ABACAVIR\LAMIVUDINE (13) EFAVIRENZ (11) RALTEGRAVIR (11) DOLUTEGRAVIR\RILPIVIRINE (9) BICTEGRAVIR\EMTRICITABINE\TENOFOVIR ALAFENAMIDE (7)

Related Pages

DOLUTEGRAVIR\LAMIVUDINE Full Profile All Hiv test Drugs DOLUTEGRAVIR\LAMIVUDINE Demographics DOLUTEGRAVIR\LAMIVUDINE Timeline